コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 XL1 mutations occur in patients with Bohring-Opitz syndrome.
2 metabolic disorders such as the Smith-Lemli-Opitz syndrome.
3 delay found in individuals with Smith-Lemli-Opitz syndrome.
4 ve gene for the human developmental disorder Opitz syndrome.
5 cholesterol, such as those with Smith-Lemli-Opitz syndrome.
6 by another group and found to be mutated in Opitz syndrome.
7 astating developmental disorder, Smith-Lemli-Opitz syndrome.
8 re frequent in myeloid leukemias and Bohring-Opitz syndrome.
9 lesterol (7-DHC), accumulates in Smith-Lemli-Opitz syndrome, a human genetic disease that phenocopies
12 ay a fundamental role in the pathogenesis of Opitz syndrome and in morphogenetic events at the midlin
13 as levels of cleaved alpha4 are decreased in Opitz syndrome and increased in Alzheimer disease, disor
14 of the cleft palate component of Smith-Lemli-Opitz syndrome and other human malformation syndromes in
15 sis dwf5 phenotype and the human Smith-Lemli-Opitz syndrome are caused by loss-of-function mutations
16 m 7-DHC that also accumulates in Smith-Lemli-Opitz syndrome, blocked Hedgehog signaling by inhibiting
18 malformation syndromes including Smith-Lemli-Opitz syndrome, desmosterolosis, CHILD syndrome, CDPX2 a
19 novel MAP, GLFND, that shows homology to the Opitz syndrome gene product [6], localizes to a subpopul
20 cholesterol, the RSH (so-called Smith-Lemli-Opitz) syndrome has become a paradigmatic metabolic malf
21 l in the plasma of children with Smith-Lemli-Opitz syndrome imply that intermediates in cholesterol s
23 alformation syndromes, including Smith-Lemli-Opitz syndrome, lathosterolosis, desmosterolosis, X-link
26 d by nocodazole or by siRNA knockdown of the Opitz syndrome protein Mid1 that binds alpha-4 to microt
29 orn error of metabolism known as Smith-Lemli-Opitz syndrome (SLOS) caused by defective cholesterol bi
38 n human fibroblasts derived from Smith-Lemli-Opitz syndrome (SLOS) patients and linked to specific tr
40 rol reductase is associated with Smith-Lemli-Opitz syndrome (SLOS), the potent and selective inhibito
45 ol present in elevated levels in Smith-Lemli-Opitz syndrome, were both significantly more strongly do
46 olesterol biosynthetic disorder, Smith-Lemli-Opitz syndrome, whose underlying defect was identified i
47 ant roles in the pathogenesis of Smith-Lemli-Opitz syndrome, X-linked dominant chondrodysplasia punct
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。